Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Dylgjeri

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer Research|December 11, 2021
DNA-PKcs: A Targetable Protumorigenic Protein KinaseEmanuela Dylgjeri, Karen E Knudsen
Scientific Reports|September 13, 2016
WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent mannerShruti Lal, Mahsa Zarei, Saswati N Chand, et al.
Oncogene|November 13, 2021
Mutant p53 elicits context-dependent pro-tumorigenic phenotypesJennifer J McCann, Irina A Vasilevskaya, Christopher McNair, et al.
The Oncologist|July 1, 2025
Mitigation and management of adverse events associated with amivantamab therapyNarjust Florez, Nicole R LeBoeuf, Julia Rotow, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancerNicolas Gordon, Peter T Gallagher, Neermala Poudel Neupane, et al.
Molecular Oncology|January 14, 2026
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancerNicolas Gordon, Peter T Gallagher, Orly I Richter, et al.
Cancer Research|October 9, 2021
Novel Oncogenic Transcription Factor Cooperation in RB-Deficient CancerAmy C Mandigo, Ayesha A Shafi, Jennifer J McCann, et al.
Cancer Research|November 20, 2019
USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA RepairJennifer J McCann, Irina A Vasilevskaya, Neermala Poudel Neupane, et al.
European Urology Oncology|November 24, 2018
Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic ResponseAyesha A Shafi, Matthew J Schiewer, Renée de Leeuw, et al.
Nature Communications|January 16, 2021
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repairAyesha A Shafi, Chris M McNair, Jennifer J McCann, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Research|December 11, 2021
DNA-PKcs: A Targetable Protumorigenic Protein KinaseEmanuela Dylgjeri, Karen E Knudsen
Scientific Reports|September 13, 2016
WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent mannerShruti Lal, Mahsa Zarei, Saswati N Chand, et al.
Oncogene|November 13, 2021
Mutant p53 elicits context-dependent pro-tumorigenic phenotypesJennifer J McCann, Irina A Vasilevskaya, Christopher McNair, et al.
The Oncologist|July 1, 2025
Mitigation and management of adverse events associated with amivantamab therapyNarjust Florez, Nicole R LeBoeuf, Julia Rotow, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancerNicolas Gordon, Peter T Gallagher, Neermala Poudel Neupane, et al.
Molecular Oncology|January 14, 2026
PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancerNicolas Gordon, Peter T Gallagher, Orly I Richter, et al.
Cancer Research|October 9, 2021
Novel Oncogenic Transcription Factor Cooperation in RB-Deficient CancerAmy C Mandigo, Ayesha A Shafi, Jennifer J McCann, et al.
Cancer Research|November 20, 2019
USP22 Functions as an Oncogenic Driver in Prostate Cancer by Regulating Cell Proliferation and DNA RepairJennifer J McCann, Irina A Vasilevskaya, Neermala Poudel Neupane, et al.
European Urology Oncology|November 24, 2018
Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic ResponseAyesha A Shafi, Matthew J Schiewer, Renée de Leeuw, et al.
Nature Communications|January 16, 2021
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repairAyesha A Shafi, Chris M McNair, Jennifer J McCann, et al.
Pageof 2